pmid,title,journal,year,drug,disease
19744184,Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily.,European journal of clinical investigation,2009,Dasatinib,Chronic Active Epstein-Barr Virus Infection
17077147,Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice.,Proceedings of the National Academy of Sciences of the United States of America,2006,Dasatinib,Chronic Active Epstein-Barr Virus Infection
